Abstract
Purpose
This study examined targeted genomic variants of transforming growth factor beta (TGFB) signaling in Appalachian women. Appalachian women with cervical cancer were compared to healthy Appalachian counterparts to determine whether these polymorphic alleles were over-represented within this high-risk cancer population, and whether lifestyle or environmental factors modified the aggregate genetic risk in these Appalachian women.
Methods
Appalachian women’s survey data and blood samples from the Community Awareness, Resources, and Education (CARE) CARE I and CARE II studies (n = 163 invasive cervical cancer cases, 842 controls) were used to assess gene–environment interactions and cancer risk. Polymorphic allele frequencies and socio-behavioral demographic measurements were compared using t tests and χ2 tests. Multivariable logistic regression was used to evaluate interaction effects between genomic variance and demographic, behavioral, and environmental characteristics.
Results
Several alleles demonstrated significant interaction with smoking (TP53 rs1042522, TGFB1 rs1800469), alcohol consumption (NQO1 rs1800566), and sexual intercourse before the age of 18 (TGFBR1 rs11466445, TGFBR1 rs7034462, TGFBR1 rs11568785). Interestingly, we noted a significant interaction between “Appalachian self-identity” variables and NQO1 rs1800566. Multivariable logistic regression of cancer status in an over-dominant TGFB1 rs1800469/TGFBR1 rs11568785 model demonstrated a 3.03-fold reduction in cervical cancer odds. Similar decreased odds (2.78-fold) were observed in an over-dominant TGFB1 rs1800469/TGFBR1 rs7034462 model in subjects who had no sexual intercourse before age 18.
Conclusions
This study reports novel associations between common low-penetrance alleles in the TGFB signaling cascade and modified risk of cervical cancer in Appalachian women. Furthermore, our unexpected findings associating Appalachian identity and NQO1 rs1800566 suggests that the complex environmental exposures that contribute to Appalachian self-identity in Appalachian cervical cancer patients represent an emerging avenue of scientific exploration.
Similar content being viewed by others
References
Ervik M, Lam F, Ferlay J, Mery L, Soerjomataram I, Bray F (2018) Cancer today. International Agency for Research on Cancer. http://gco.iarc.fr/today/home. Accessed Feb 2019
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
Bray F, Ren J-S, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132(5):1133–1145. https://doi.org/10.1002/ijc.27711
Appalachian Community Cancer Network (2010) Addressing the cancer burden in Appalachian communities
Appalachian Regional Commission (2015) Appalachia then and now: examining changes to the Appalachian region since 1965
Appalachian Regional Commission (2019) Appalachian Regional Commission. https://www.arc.gov/index.asp. Accessed Feb 2019
Behringer B, Friedell GH (2006) Appalachia: where place matters in health. Prev Chronic Dis. 3(4):A113
Behringer B, Friedell GH, Dorgan KA et al (2007) Understanding the challenges of reducing cancer in Appalachia: addressing a place-based health disparity population. Californian J Heal Promot Disparities Soc Justice. 5:40–49
Wewers ME, Katz M, Fickle D, Paskett ED (2006) Risky behaviors among Ohio Appalachian adults. Prev Chronic Dis. 3(4):A127
Lengerich EJ, Tucker TC, Powell RK et al (2005) Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia. J Rural Health. 21(1):39–47
Pickup M, Novitskiy S, Moses HL (2013) The roles of TGFβ in the tumour microenvironment. Nat Rev Cancer 13(11):788–799. https://doi.org/10.1038/nrc3603
Pasche B, Pennison MJ, Jimenez H, Wang M (2014) TGFBR1 and cancer susceptibility. Trans Am Clin Climatol Assoc 125:300–312
Martelossi Cebinelli GC, Paiva Trugilo K, Badaró Garcia S, Brajão de Oliveira K (2016) TGF-β1 functional polymorphisms: a review. Eur Cytokine Netw 27(4):81–89. https://doi.org/10.1684/ecn.2016.0382
Levovitz C, Chen D, Ivansson E, Gyllensten U, Finnigan JP, Alshawish S, Zhang W, Schadt EE, Posner MR, Genden EM, Boffetta P, Sikora AG (2014) TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer. Cancer Res 74(23):6833–6844. https://doi.org/10.1158/0008-5472.CAN-14-0602-T Epub 2014 Oct 1
Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, Pinkston CM, John EM, Hines LM, Stern MC, Giuliano AR, Torres-Mejia G, Brock GN, Groves FD, Kerber RA, Wolff RK, Slattery ML (2013) Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women. Breast Cancer Res Treat 141(2):287–297. https://doi.org/10.1007/s10549-013-2690-z (Epub 2013 Sep 14)
Bellam N, Pasche B (2010) Tgf-beta signaling alterations and colon cancer. Cancer Treat Res 155:85–103. https://doi.org/10.1007/978-1-4419-6033-7_5
Di QG, Sun BH, Jiang MM, Du JF, Mai ZT, Zhang X, Zhou LR, Chi YM, Lv J (2017) Polymorphisms of -800G/A and +915G/C in TGF-β1 gene and lung cancer susceptibility. Oncol Lett. 14(1):733–736. https://doi.org/10.3892/ol.2017.6173 (Epub 2017 May 16)
Wan PQ, Wu JZ, Huang LY, Wu JL, Wei YH, Ning QY (2015) TGF-β1 polymorphisms and familial aggregation of liver cancer in Guangxi, China. Genet Mol Res 14(3):8147–8160. https://doi.org/10.4238/2015.July.27.3
Shi Q, Wang X, Cai C, Yang S, Huo N, Liu H (2017) Association between TGF-β1 polymorphisms and head and neck cancer risk: a meta-analysis. Front Genet. 8:169. https://doi.org/10.3389/fgene.2017.00169
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK et al (2016) Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 7(43):69097–69110. https://doi.org/10.18632/oncotarget.10215
Yang L, Wang YJ, Zheng LY, Jia YM, Chen YL, Chen L, Liu DG, Li XH, Guo HY, Sun YL, Tian XX, Fang WG (2016) Genetic polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 are associated with endometrial cancer susceptibility in Chinese han women. PLoS ONE 11(5):e0155270. https://doi.org/10.1371/journal.pone.0155270
Singh H, Jain M, Mittal B (2009) Role of TGF-beta1 (-509C > T) promoter polymorphism in susceptibility to cervical cancer. Oncol Res 18(1):41–45
Al-Harbi NM, Bin Judia SS, Mishra KN, Shoukri MM, Alsbeih GA (2017) Genetic predisposition to cervical cancer and the association with XRCC1 and TGFB1 polymorphisms. Int J Gynecol Cancer. 27(9):1949–1956. https://doi.org/10.1097/IGC.0000000000001103
Gautam KA, Pooja S, Sankhwar SN, Sankhwar PL, Goel A, Rajender S (2015) c.29C > T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer. Cytokine 75(2):344–348. https://doi.org/10.1016/j.cyto.2015.05.017
Pasche B, Knobloch TJ, Bian Y et al (2005) Somatic acquisition and signaling of TGFBR1*6A in cancer. J Am Med Assoc 294(13):1634–1646. https://doi.org/10.1001/jama.294.13.1634
Zhang H-T, Zhao J, Zheng S-Y, Chen X-F (2005) Is TGFBR1 *6A really associated with increased risk of cancer? J Clin Oncol 23(30):7743–7744. https://doi.org/10.1200/JCO.2005.02.9108
Bian Y, Knobloch TJ, Sadim M et al (2007) Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. Hum Mol Genet 16(24):3128–3135. https://doi.org/10.1093/hmg/ddm274
ClinicalTrials.gov. community awareness, resources and education (CARE I): NCT02113514 (2018). https://www.clinicaltrials.gov/ct2/show/NCT02113514.
ClinicalTrials.gov. Community awareness, resources and education (CARE II): NCT01299714 (2018). https://www.clinicaltrials.gov/ct2/show/NCT01299714.
Reiter PL, Katz ML, Ruffin MT et al (2013) HPV prevalence among women from Appalachia: results from the CARE project. PLoS ONE 8(8):e74276. https://doi.org/10.1371/journal.pone.0074276
Weaver R (2016) Appalachia, USA: an empirical note and agenda for future research. J Rural Soc Sci. 31(1):23–52
Reiter PL, Katz ML, Ferketich AK, Ruffin MT, Paskett ED (2009) Appalachian self-identity among women in Ohio appalachia. J Rural Commun Psychol E12(1)
Wilson RJ, Ryerson AB, Singh SD, King JB (2016) Cancer incidence in Appalachia, 2004–2011. Cancer Epidemiol Biomarkers Prev 25(2):250–258. https://doi.org/10.1158/1055-9965.EPI-15-0946
Erichsen HC, Chanock SJ (2004) SNPs in cancer research and treatment. Br J Cancer 90(4):747–751. https://doi.org/10.1038/sj.bjc.6601574
Guengerich FP (1998) The environmental genome project: functional analysis of polymorphisms. Environ Health Perspect 106(7):365–368
dbSNP: database for short genetic variations scope and access searching for and displaying SNP records
Silverman ES, Palmer LJ, Subramaniam V et al (2004) Transforming growth factor-β 1 promoter polymorphism C–509T Is associated with asthma. Am J Respir Crit Care Med 169(2):214–219. https://doi.org/10.1164/rccm.200307-973OC
Afify RAA, Salama N (2013) Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and aplastic anemia. Comp Clin Path. 22(4):755–760. https://doi.org/10.1007/s00580-012-1478-6
Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8(1):93–97
Jin G, Wang L, Chen W et al (2007) Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer 120(6):1330–1335. https://doi.org/10.1002/ijc.22443
García-Rocha R, Moreno-Lafont M, Mora-García ML et al (2015) Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity. Cytokine 76(2):382–390. https://doi.org/10.1016/j.cyto.2015.09.001
Lane DP (1992) p53, guardian of the genome. Nature 358(6381):15–16. https://doi.org/10.1038/358015a0
Gracy G, Sadhna K, Jacqueline J, Deepika K (2014) Highlights of p53 mutation and it’s role in cervical cancer metastasis. Int J Biol Med Res 5(1):3772–3779
Chen R, Liu S, Ye H et al (2015) Association of p53 rs1042522, MDM2 rs2279744 and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population. Sci Rep. 5(1):13300. https://doi.org/10.1038/srep13300
Jee SH, Won SY, Yun JE, Lee JE, Park JS, Ji SS (2004) Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynecol Obstet. 85(3):301–308. https://doi.org/10.1016/j.ijgo.2003.08.017
Klug SJ, Ressing M, Koenig J et al (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 10(8):772–784. https://doi.org/10.1016/S1470-2045(09)70187-1
Stumbar SE, Stevens M, Feld Z (2019) Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management. Prim Care 46(1):117–134. https://doi.org/10.1016/j.pop.2018.10.011 (Epub 2018 Dec 22)
Wang X, Huang X, Zhang Y (2018) Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 9:2896. https://doi.org/10.3389/fmicb.2018.02896
Khani Y, Pourgholam-Amiji N, Afshar M, Otroshi O, Sharifi-Esfahani M, Sadeghi-Gandomani H, Vejdani M, Salehiniya H (2018) Tobacco smoking and cancer types: a review. Biomed Res Ther 5(4):2142–2159. https://doi.org/10.15419/bmrat.v5i4.428
Johnson CA, James D, Marzan A, Armaos M (2019) Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. https://doi.org/10.1016/j.soncn.2019.02.003
Su B, Qin W, Xue F, Wei X, Guan Q, Jiang W, Wang S, Xu M, Yu S (2018) The relation of passive smoking with cervical cancer: a systematic review and meta-analysis. Medicine 97(46):e13061. https://doi.org/10.1097/MD.0000000000013061
Collins S, Rollason TP, Young LS, Woodman CB (2010) Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer 46(2):405–411. https://doi.org/10.1016/j.ejca.2009.09.015 (Epub 2009 Oct 12)
International Agency for Research on Cancer (2012) IARC monographs on the evaluation of carcinogenic risks to humans. Personal habits and indoor combustions: tobacco smoking, vol 100E. IARC, Lyon
Fonseca-Moutinho JA (2011) Smoking and cervical cancer. ISRN Obstet Gynecol. 2011:1–6. https://doi.org/10.5402/2011/847684
Hecht SS (2014) It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco. Cancer Prev Res. 7(7):639–647. https://doi.org/10.1158/1940-6207.CAPR-14-0095
Xue J, Yang S, Seng S (2014) Mechanisms of cancer induction by tobacco-specific NNK and NNN. Cancer 6(2):1138–1156
Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA (2016) Breaking the DNA damage response to improve cervical cancer treatment. Cancer Treat Rev 42:30–40. https://doi.org/10.1016/j.ctrv.2015.11.008 (Epub 2015 Nov 24)
Plummer M, Herrero R, Franceschi S et al (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study. Cancer Causes Control 14(9):805–814
Gibson G (2012) Rare and common variants: twenty arguments. Nat Rev Genet 13(2):135–145. https://doi.org/10.1038/nrg3118
Saint Pierre A, Génin E (2014) How important are rare variants in common disease? Brief Funct Genomics. 13(5):353–361. https://doi.org/10.1093/bfgp/elu025
Woychik R (2014) Where exposure science and citizen science meet. Research Triangle Environmental Health Collaborative. Environ Heal Summit @BULLET Recomm from Res Triangle Environ Heal Collab Environ Heal Summit
Langston MA, Levine RS, Kilbourne BJ et al (2014) Scalable combinatorial tools for health disparities research. Int J Environ Res Public Health. 11(10):10419–10443. https://doi.org/10.3390/ijerph111010419
Juarez PD, Matthews-Juarez P, Hood DB et al (2014) The public health exposome: a population-based, exposure science approach to health disparities research. Int J Environ Res Public Health. 11(12):12866–12895. https://doi.org/10.3390/ijerph111212866
U.S. Department of Health and Human Services (USDHHS), National Institute of Health (NIH) NI of EHS (NIEHS) (2017) Advancing science, improving health: a plan for environmental health research. NIEHS 2012–2017. https://www.niehs.nih.gov/about/strategicplan/strategicplan2012/index.cfm. Accessed 25 Jun 2018
Post DM, Gehlert S, Hade EM, Reiter PL, Ruffin M, Paskett ED (2013) Depression and SES in women from Appalachia. J Rural Ment Heal. 37(1):2–15. https://doi.org/10.1037/rmh0000001
Oyana TJ, Matthews-Juarez P, Cormier SA, Xu X, Juarez PD (2015) Using an external exposome framework to examine pregnancy-related morbidities and mortalities: implications for health disparities research. Int J Environ Res Public Health. 13(1):ijerph13010013. https://doi.org/10.3390/ijerph13010013
Schootman M, Gomez SL, Henry KA et al (2017) Geospatial approaches to cancer control and population sciences. Cancer Epidemiol Biomark Prev 26(4):472–475. https://doi.org/10.1158/1055-9965.EPI-17-0104
Korycinski RW, Tennant BL, Cawley MA, Bloodgood B, Oh AY, Berrigan D (2018) Geospatial approaches to cancer control and population sciences at the United States cancer centers. Cancer Causes Control 29(3):371–377. https://doi.org/10.1007/s10552-018-1009-0
Smith BE (2015) Representing Appalachia: the impossible necessity of Appalachian studies. In: Berry C, Obermiller PJ, Scott SL (eds) Studying Appalachian studies: making the path by walking. University of Illinois Press, Urbana, IL
Yang S, Jin T, Su H-X et al (2015) The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies. PLoS ONE 10(1):e0116500. https://doi.org/10.1371/journal.pone.0116500
Yu H, Liu H, Wang L-E, Wei Q (2012) A functional NQO1 609C > T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS ONE 7(1):e30566. https://doi.org/10.1371/journal.pone.0030566
Oh E-T, Park HJ (2015) Implications of NQO1 in cancer therapy. BMB Rep. 48(11):609–617
Atia A, Alrawaiq N, Abdullah A (2014) A review of NAD(P)H: quinone oxidoreductase 1 (NQO1); a multifunctional antioxidant enzyme. J Appl Pharm Sci. 4(12):118–122. https://doi.org/10.7324/JAPS.2014.41220
Peng Q, Lu Y, Lao X et al (2014) The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol. 9(1):100. https://doi.org/10.1186/1746-1596-9-100
Asher G, Lotem J, Sachs L, Kahana C, Shaul Y (2002) Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 99(20):13125–13130. https://doi.org/10.1073/pnas.202480499
Asher G, Lotem J, Kama R, Sachs L, Shaul Y (2002) NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 99(5):3099–3104. https://doi.org/10.1073/pnas.052706799
Vrijheid M (2014) The exposome: a new paradigm to study the impact of environment on health. Thorax 69(9):876–878. https://doi.org/10.1136/thoraxjnl-2013-204949
Wild CP, Scalbert A, Herceg Z (2013) Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagen 54(7):480–499. https://doi.org/10.1002/em.21777
Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS (2010) TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomark Prev 19(3):755–761. https://doi.org/10.1158/1055-9965.EPI-09-0886 (Epub 2010 Mar 3)
Radloff LS (1977) The CES-D scale. Appl Psychol Meas 1(3):385–401. https://doi.org/10.1177/014662167700100306
Acknowledgments
The study was supported by grants from the National Institutes of Health’s National Cancer Institute (P50 CA105632, P30 CA016058) and National Center for Advancing Translational Science (UL1TR001070).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Knobloch, T.J., Peng, J., Hade, E.M. et al. Inherited alterations of TGF beta signaling components in Appalachian cervical cancers. Cancer Causes Control 30, 1087–1100 (2019). https://doi.org/10.1007/s10552-019-01221-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-019-01221-y